Stock price history for Neurocrine Biosciences (NBIX)

Highest end of day price: C$212.72 CAD on 2025-12-10

Lowest end of day price: C$2.73 CAD on 2009-11-12

Stock price history of Neurocrine Biosciences from 1996 to 2026

Annual Stock Price Performance

Year	Performance
2026	-6.05%
2025	2.88%
2024	3.62%
2023	9.73%
2022	35.01%
2021	-11.16%
2020	-11.50%
2019	53.36%
2018	-9.95%
2017	100.70%
2016	-26.07%
2015	147.68%
2014	133.93%
2013	14.74%
2012	-12.51%
2011	10.82%
2010	184.01%
2009	-16.82%
2008	-29.20%
2007	-55.79%
2006	-83.61%
2005	27.97%
2004	-11.17%
2003	20.11%
2002	-9.71%
2001	59.41%
2000	31.84%
1999	260.00%
1998	-17.29%
1997	-17.65%
1996	-20.00%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Pfizer PFE	C$37.67	1.25%	🇺🇸 USA
AbbVie ABBV	C$284.81	-0.29%	🇺🇸 USA
Eli Lilly LLY	C$1,267	2.55%	🇺🇸 USA
Repligen RGEN	C$179.34	3.24%	🇺🇸 USA
Athersys ATHX	C$0.01845	-33.50%	🇺🇸 USA
ANI Pharmaceuticals ANIP	C$110.60	3.65%	🇺🇸 USA
Palatin Technologies PTN	C$30.75	7.66%	🇺🇸 USA
Royalty Pharma RPRX	C$68.34	3.14%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions